Niciu Mark J, Abdallah Chadi G, Fenton Lisa R, Fasula Madonna K, Black Anne, Anderson George M, Sanacora Gerard
National Institutes of Health, National Institute of Mental Health, Experimental Therapeutics and Pathophysiology Branch, Building 10/CRC, 10 Center Dr., Bethesda, MD 20892, USA.
Yale University Department of Psychiatry/Connecticut Mental Health Center, Abraham Ribicoff Research Facilities, 34 Park St., 3rd floor, New Haven, CT 06519, USA; Clinical Neuroscience Division, Veterans Affairs National Center for PTSD, Veterans Affairs Connecticut Healthcare System, 950 Campbell Ave., West Haven, CT 06516, USA.
J Affect Disord. 2015 Nov 15;187:241-4. doi: 10.1016/j.jad.2015.08.026. Epub 2015 Aug 19.
There is a clinical need for evidence-based psychotherapy response biomarkers in major depressive disorder (MDD). Based on previous studies, we hypothesized that lower 24-h urinary cortisol levels and a history of early life stress/trauma would predict an improved antidepressant response to cognitive-behavioral therapy (CBT).
50 currently depressed MDD subjects were enrolled. 24-h urine was collected and measured for cortisol levels by radioimmunoassay (RIA). Subjects were also administered early life stress/trauma measures at baseline: Global Perceived Early-Life Stress (GPELS), The Early Life Trauma Inventory (ELTI) and Klein Loss Scale (KLS). The efficacy of a twelve-week course of once-weekly CBT was evaluated by the primary outcome measure, the 24-item Hamilton Depression Rating Scale (HDRS24), at baseline and every four weeks, and the Beck Depression Inventory at baseline and weekly thereafter. 42 subjects had at least one complete follow-up visit (≥4 weeks of CBT), and 30 subjects completed the full 12-week course.
Baseline 24-h urinary cortisol levels did not correlate with CBT's antidepressant response. Higher KLS scores, a measure of early life parental loss or separation, correlated with delta HDRS24 (rs=-0.39, padjusted=0.05). Complementary general linear model analysis revealed enhanced CBT efficacy in patients with a history of early life parental loss or separation [F(1,35)=6.65, p=0.01].
Small sample size, Treatment-naïve population.
Early life parental separation or loss positively correlated with CBT's antidepressant efficacy in our sample and may warrant further study in larger clinical samples.
在重度抑郁症(MDD)中,临床上需要基于证据的心理治疗反应生物标志物。基于先前的研究,我们假设较低的24小时尿皮质醇水平以及早年生活压力/创伤史可预测认知行为疗法(CBT)的抗抑郁反应改善。
招募了50名目前患有抑郁症的MDD患者。收集24小时尿液,通过放射免疫分析(RIA)测量皮质醇水平。在基线时还对受试者进行了早年生活压力/创伤测量:总体感知早年生活压力(GPELS)、早年生活创伤量表(ELTI)和克莱因丧失量表(KLS)。通过主要结局指标,即24项汉密尔顿抑郁量表(HDRS24)在基线时以及每四周进行评估,以及在基线时和此后每周进行贝克抑郁量表评估,来评估为期十二周、每周一次的CBT疗程的疗效。42名受试者至少有一次完整的随访(≥4周的CBT),30名受试者完成了完整的12周疗程。
基线24小时尿皮质醇水平与CBT的抗抑郁反应无关。较高的KLS评分,即早年父母丧失或分离的测量指标,与HDRS24的变化相关(rs=-0.39,校正后p=0.05)。补充性一般线性模型分析显示,有早年父母丧失或分离史的患者CBT疗效增强[F(1,35)=6.65,p=0.01]。
样本量小,未接受过治疗的人群。
在我们的样本中早年父母分离或丧失与CBT的抗抑郁疗效呈正相关,可能值得在更大的临床样本中进一步研究。